{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:55:51Z","timestamp":1792691751957,"version":"4.5.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>High tumor recurrence and dismal survival rates after curative intended resection for hepatocellular carcinoma (HCC) are still concerning. The primary goal was to assess predictive factors associated with disease-free (DFS) and overall survival (OS) in a subset of patients with HCC undergoing hepatic resection (HR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Between 08\/2004\u20137\/2021, HR for HCC was performed in 188 patients at our institution. Data allocation was conducted from a prospectively maintained database. The prognostic impact of clinico-pathological factors on DFS and OS was assessed by using uni- and multivariate Cox regression analyses. Survival curves were generated with the Kaplan Meier method.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The postoperative 1-, 3- and 5- year overall DFS and OS rates were 77.9%, 49.7%, 41% and 72.7%, 54.7%, 38.8%, respectively. Tumor diameter\u2009\u2265\u200945\u00a0mm [HR 1.725; (95% CI 1.091\u20132.727); <jats:italic>p<\/jats:italic>\u2009=\u20090.020], intra-abdominal abscess [HR 3.812; (95% CI 1.859\u20137.815); <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001], and preoperative chronic alcohol abuse [HR 1.831; (95% CI 1.102\u20133.042); <jats:italic>p<\/jats:italic>\u2009=\u20090.020] were independently predictive for DFS while diabetes mellitus [HR 1.714; (95% CI 1.147\u20132.561); <jats:italic>p<\/jats:italic>\u2009=\u20090.009), M-Stage [HR 2.656; (95% CI 1.034\u20136.826); <jats:italic>p<\/jats:italic>\u2009=\u20090.042], V-Stage [HR 1.946; (95% CI 1.299\u20132.915); <jats:italic>p<\/jats:italic>\u2009=\u20090.001, Sepsis [HR 10.999; (95% CI 5.167\u201323.412); <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001], and ISGLS B\/C [HR 2.008; (95% CI 1.273\u20133.168); <jats:italic>p<\/jats:italic>\u2009=\u20090.003] were significant determinants of OS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Despite high postoperative recurrence rates, an acceptable long-term survival in patients after curative HR could be achieved. The Identification of parameters related to OS and DFS improves patient-centered treatment and surveillance strategies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12893-024-02399-y","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T12:02:43Z","timestamp":1712577763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Which factors predict tumor recurrence and survival after curative hepatectomy in hepatocellular carcinoma? Results from a European institution"],"prefix":"10.1186","volume":"24","author":[{"given":"Sascha","family":"Vaghiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Prassas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Mustafov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Kalmuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram Trudo","family":"Knoefel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadja","family":"Lehwald-Tywuschik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Dizdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"issue":"3","key":"2399_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2399_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2399_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.amjmed.2006.11.020","volume":"120","author":"S Parikh","year":"2007","unstructured":"Parikh S, Hyman D. Hepatocellular cancer: a guide for the internist. Am J Med. 2007;120(3):194\u2013202.","journal-title":"Am J Med"},{"issue":"4","key":"2399_CR4","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jamcollsurg.2014.12.030","volume":"220","author":"WC Chapman","year":"2015","unstructured":"Chapman WC, Klintmalm G, Hemming A, Vachharajani N, Majella Doyle MB, DeMatteo R, et al. Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified? J Am Coll Surg. 2015;220(4):628\u201337.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"2399_CR5","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.surg.2019.08.010","volume":"166","author":"DI Tsilimigras","year":"2019","unstructured":"Tsilimigras DI, Bagante F, Moris D, Merath K, Paredes AZ, Sahara K, et al. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients. Surgery. 2019;166(6):967\u201374.","journal-title":"Surgery"},{"issue":"1","key":"2399_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.21037\/hbsn-21-350","volume":"11","author":"JH Koh","year":"2022","unstructured":"Koh JH, Tan DJH, Ong Y, Lim WH, Ng CH, Tay PWL, et al. Liver resection versus liver transplantation for hepatocellular carcinoma within Milan criteria: a meta-analysis of 18,421 patients. Hepatobiliary Surg Nutr. 2022;11(1):78\u201393.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"5","key":"2399_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jcmgh.2020.12.009","volume":"11","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, Muthiah MD, Zhou L, Jumat H, Tan WX, Lee GH, et al. Predicting HCC Response to Multikinase Inhibitors With In Vivo Cirrhotic Mouse Model for Personalized Therapy. Cell Mol Gastroenterol Hepatol. 2021;11(5):1313\u201325.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"1","key":"2399_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jamcollsurg.2012.02.022","volume":"215","author":"MBM Doyle","year":"2012","unstructured":"Doyle MBM, Vachharajani N, Maynard E, Shenoy S, Anderson C, Wellen JR, et al. Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes. J Am Coll Surg. 2012;215(1):19\u201328 (discussion 28-30).","journal-title":"J Am Coll Surg."},{"issue":"6","key":"2399_CR9","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/TP.0000000000003174","volume":"104","author":"N Mehta","year":"2020","unstructured":"Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, et al. Liver Transplantation for Hepatocellular Carcinoma Working. Group Report from the ILTS Transplant Oncology Consensus Conference. Transplantation. 2020;104(6):1136\u201342.","journal-title":"Transplantation."},{"issue":"5","key":"2399_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1477-2574.2010.00182.x","volume":"12","author":"W Jarnagin","year":"2010","unstructured":"Jarnagin W, Chapman WC, Curley S, D\u2019Angelica M, Rosen C, Dixon E, et al. Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford). 2010;12(5):302\u201310.","journal-title":"HPB (Oxford)"},{"issue":"6","key":"2399_CR11","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/lt.24136","volume":"21","author":"ND Parikh","year":"2015","unstructured":"Parikh ND, Hutton D, Marrero W, Sanghani K, Xu Y, Lavieri M. Projections in donor organs available for liver transplantation in the United States: 2014\u20132025. Liver Transpl. 2015;21(6):855\u201363.","journal-title":"Liver Transpl"},{"issue":"7","key":"2399_CR12","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00423-021-02298-3","volume":"406","author":"N Machairas","year":"2021","unstructured":"Machairas N, Tsilimigras DI, Pawlik TM. State-of-the-art surgery for hepatocellular carcinoma. Langenbecks Arch Surg. 2021;406(7):2151\u201362.","journal-title":"Langenbecks Arch Surg"},{"issue":"3","key":"2399_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/00000658-199903000-00004","volume":"229","author":"ST Fan","year":"1999","unstructured":"Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg. 1999;229(3):322\u201330.","journal-title":"Ann Surg"},{"issue":"4","key":"2399_CR14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jamcollsurg.2007.01.035","volume":"204","author":"A Taketomi","year":"2007","unstructured":"Taketomi A, Kitagawa D, Itoh S, Harimoto N, Yamashita YI, Gion T, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma an institute\u2019s experience with 625 patients. J Am Coll Surg. 2007;204(4):580\u20137.","journal-title":"J Am Coll Surg"},{"issue":"9","key":"2399_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/archsurg.134.9.984","volume":"134","author":"G Torzilli","year":"1999","unstructured":"Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg. 1999;134(9):984\u201392.","journal-title":"Arch Surg"},{"issue":"14","key":"2399_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12957-016-0811-y","volume":"2","author":"W Liu","year":"2016","unstructured":"Liu W, Wang K, Bao Q, Sun Y, Xing BC. Hepatic resection provided long-term survival for patients with intermediate and advanced-stage resectable hepatocellular carcinoma. World J Surg Oncol. 2016;2(14):62.","journal-title":"World J Surg Oncol"},{"issue":"11","key":"2399_CR17","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1001\/archsurg.143.11.1082","volume":"143","author":"G Torzilli","year":"2008","unstructured":"Torzilli G, Donadon M, Marconi M, Palmisano A, Del Fabbro D, Spinelli A, et al. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Arch Surg. 2008;143(11):1082\u201390.","journal-title":"Arch Surg"},{"issue":"10","key":"2399_CR18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/hpb.12311","volume":"16","author":"SY Lee","year":"2014","unstructured":"Lee SY, Konstantinidis IT, Eaton AA, G\u00f6nen M, Kingham TP, D\u2019Angelica MI, et al. Predicting recurrence patterns after resection of hepatocellular cancer. HPB (Oxford). 2014;16(10):943\u201353.","journal-title":"HPB (Oxford)"},{"issue":"2","key":"2399_CR19","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","volume":"38","author":"H Imamura","year":"2003","unstructured":"Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38(2):200\u20137.","journal-title":"J Hepatol"},{"issue":"2","key":"2399_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.sla.0000197706.21803.a1","volume":"243","author":"N Portolani","year":"2006","unstructured":"Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GAM, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243(2):229\u201335.","journal-title":"Ann Surg"},{"issue":"1","key":"2399_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00000658-200007000-00003","volume":"232","author":"R Tung-Ping Poon","year":"2000","unstructured":"Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232(1):10\u201324.","journal-title":"Ann Surg"},{"issue":"4","key":"2399_CR22","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/SLA.0000000000002360","volume":"266","author":"J Zheng","year":"2017","unstructured":"Zheng J, Chou JF, G\u00f6nen M, Vachharajani N, Chapman WC, Majella Doyle MB, et al. Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort. Ann Surg. 2017;266(4):693\u2013701.","journal-title":"Ann Surg"},{"issue":"9","key":"2399_CR23","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/bjs.11231","volume":"106","author":"T Yang","year":"2019","unstructured":"Yang T, Liu K, Liu CF, Zhong Q, Zhang J, Yu JJ, et al. Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma. Br J Surg. 2019;106(9):1228\u201336.","journal-title":"Br J Surg"},{"issue":"7","key":"2399_CR24","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1053\/j.gastro.2015.02.055","volume":"148","author":"JH Lee","year":"2015","unstructured":"Lee JH, Lee JH, Lim YS, Yeon JE, Song TJ, Yu SJ, et al. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma. Gastroenterology. 2015;148(7):1383-1391.e6.","journal-title":"Gastroenterology"},{"issue":"7624","key":"2399_CR25","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138.","journal-title":"BMJ"},{"issue":"5","key":"2399_CR26","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","volume":"149","author":"NN Rahbari","year":"2011","unstructured":"Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713\u201324.","journal-title":"Surgery"},{"key":"2399_CR27","first-page":"272","volume-title":"TNM Classification of Malignant Tumours, 8th Edition","author":"Brierley","year":"2017","unstructured":"Brierley. TNM classification of malignant tumours, 8th Edition. 8th ed. Chichester, West Sussex, UK\u202f; Hoboken, NJ: Wiley-Blackwell; 2017. p. 272.","edition":"8"},{"issue":"1","key":"2399_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SLA.0000000000004808","volume":"274","author":"M Nagino","year":"2021","unstructured":"Nagino M, DeMatteo R, Lang H, Cherqui D, Malago M, Kawakatsu S, et al. Proposal of a New Comprehensive Notation for Hepatectomy: The \u201cNew World\u201d Terminology. Ann Surg. 2021;274(1):1\u20133.","journal-title":"Ann Surg"},{"issue":"2","key":"2399_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187\u201396.","journal-title":"Ann Surg"},{"issue":"8","key":"2399_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"key":"2399_CR31","unstructured":"DIMDI - ICD-10-GM Version\u00a02018. Available from: https:\/\/www.dimdi.de\/static\/de\/klassifikationen\/icd\/icd-10-gm\/kode-suche\/htmlgm2018\/ Cited 2024 Feb. 18"},{"issue":"2","key":"2399_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s11605-009-1085-2","volume":"14","author":"W de Graaf","year":"2010","unstructured":"de Graaf W, van Lienden KP, Dinant S, Roelofs JJTH, Busch ORC, Gouma DJ, et al. Assessment of Future Remnant Liver Function Using Hepatobiliary Scintigraphy in Patients Undergoing Major Liver Resection. J Gastrointest Surg. 2010;14(2):369\u201378.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"2399_CR33","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.3390\/curroncol30030249","volume":"30","author":"A Alexander","year":"2023","unstructured":"Alexander A, Lehwald-Tywuschik N, Rehders A, Dizdar L, Fluegen G, Safi SA, et al. Optimizing Growth of the Future Liver Remnant and Making In-Situ Liver Transsection Safe-A Standardized Approach to ISLT or ALPPS. Curr Oncol. 2023;30(3):3277\u201388.","journal-title":"Curr Oncol"},{"issue":"19","key":"2399_CR34","doi-asserted-by":"publisher","first-page":"5802","DOI":"10.3390\/jcm11195802","volume":"11","author":"L Penzkofer","year":"2022","unstructured":"Penzkofer L, Mittler J, Heinrich S, Wachter N, Straub BK, Kloeckner R, et al. Outcome after Resection for Hepatocellular Carcinoma in Noncirrhotic Liver-A Single Centre Study. J Clin Med. 2022;11(19):5802.","journal-title":"J Clin Med"},{"issue":"8","key":"2399_CR35","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1245\/s10434-007-9415-7","volume":"14","author":"K Shimada","year":"2007","unstructured":"Shimada K, Sakamoto Y, Esaki M, Kosuge T, Morizane C, Ikeda M, et al. Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol. 2007;14(8):2337\u201347.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"2399_CR36","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s12094-015-1446-0","volume":"18","author":"TT Zhang","year":"2016","unstructured":"Zhang TT, Zhao XQ, Liu Z, Mao ZY, Bai L. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients. Clin Transl Oncol. 2016;18(8):831\u201340.","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"2399_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00432-010-0909-5","volume":"137","author":"XY Lu","year":"2011","unstructured":"Lu XY, Xi T, Lau WY, Dong H, Xian ZH, Yu H, et al. Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior. J Cancer Res Clin Oncol. 2011;137(4):567\u201375.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"2399_CR38","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.3748\/wjg.v22.i9.2749","volume":"22","author":"XQ Gu","year":"2016","unstructured":"Gu XQ, Zheng WP, Teng DH, Sun JS, Zheng H. Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients. World J Gastroenterol. 2016;22(9):2749\u201359.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2399_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-2007-1007122","volume":"19","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Br\u00fa C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19(3):329\u201338.","journal-title":"Semin Liver Dis"},{"issue":"6","key":"2399_CR40","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","volume":"69","author":"AWH Chan","year":"2018","unstructured":"Chan AWH, Zhong J, Berhane S, Toyoda H, Cucchetti A, Shi K, et al. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J Hepatol. 2018;69(6):1284\u201393.","journal-title":"J Hepatol"},{"issue":"9","key":"2399_CR41","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/lt.25194","volume":"24","author":"TH Welling","year":"2018","unstructured":"Welling TH, Eddinger K, Carrier K, Zhu D, Kleaveland T, Moore DE, et al. Multicenter Study of Staging and Therapeutic Predictors of Hepatocellular Carcinoma Recurrence Following Transplantation. Liver Transpl. 2018;24(9):1233\u201342.","journal-title":"Liver Transpl"},{"issue":"3","key":"2399_CR42","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/1097-0142(19900801)66:3<498::AID-CNCR2820660316>3.0.CO;2-2","volume":"66","author":"WM Cong","year":"1990","unstructured":"Cong WM, Wu MC. The biopathologic characteristics of DNA content of hepatocellular carcinomas. Cancer. 1990;66(3):498\u2013501.","journal-title":"Cancer"},{"issue":"3","key":"2399_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/jso.24501","volume":"115","author":"K Wakayama","year":"2017","unstructured":"Wakayama K, Kamiyama T, Yokoo H, Orimo T, Shimada S, Einama T, et al. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection. J Surg Oncol. 2017;115(3):324\u20139.","journal-title":"J Surg Oncol"},{"issue":"8","key":"2399_CR44","doi-asserted-by":"publisher","first-page":"300060520945552","DOI":"10.1177\/0300060520945552","volume":"48","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Gu L, Chen T, Zheng G, Ye C, Jia W. Factors influencing early recurrence of hepatocellular carcinoma after curative resection. J Int Med Res. 2020;48(8):300060520945552.","journal-title":"J Int Med Res"},{"issue":"11","key":"2399_CR45","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693\u20139.","journal-title":"N Engl J Med"},{"issue":"6","key":"2399_CR46","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","volume":"33","author":"FY Yao","year":"2001","unstructured":"Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33(6):1394\u2013403.","journal-title":"Hepatology"},{"issue":"4","key":"2399_CR47","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","volume":"143","author":"C Duvoux","year":"2012","unstructured":"Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, et al. Liver transplantation for hepatocellular carcinoma: a model including \u03b1-fetoprotein improves the performance of Milan criteria. Gastroenterology. 2012;143(4):986\u201394 (e3; quiz e14-15).","journal-title":"Gastroenterology."},{"issue":"3","key":"2399_CR48","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2016.10.038","volume":"66","author":"A Notarpaolo","year":"2017","unstructured":"Notarpaolo A, Layese R, Magistri P, Gambato M, Colledan M, Magini G, et al. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC. J Hepatol. 2017;66(3):552\u20139.","journal-title":"J Hepatol"},{"issue":"5","key":"2399_CR49","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/tri.13858","volume":"34","author":"AD Mazzotta","year":"2021","unstructured":"Mazzotta AD, Pascale A, Cano L, Rosmorduc O, Allard MA, Sa Cunha A, et al. Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha-fetoprotein score: a new prognostic risk factor. Transpl Int. 2021;34(5):954\u201363.","journal-title":"Transpl Int"},{"issue":"20","key":"2399_CR50","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.3748\/wjg.v20.i20.5935","volume":"20","author":"A Colecchia","year":"2014","unstructured":"Colecchia A, Schiumerini R, Cucchetti A, Cescon M, Taddia M, Marasco G, et al. Prognostic factors for hepatocellular carcinoma recurrence. World J Gastroenterol. 2014;20(20):5935\u201350.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"2399_CR51","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00423-018-1715-9","volume":"403","author":"G Lurje","year":"2018","unstructured":"Lurje G, Bednarsch J, Czigany Z, Amygdalos I, Meister F, Sch\u00f6ning W, et al. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent. Langenbecks Arch Surg. 2018;403(7):851\u201361.","journal-title":"Langenbecks Arch Surg"},{"issue":"3","key":"2399_CR52","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.gastro.2009.06.003","volume":"137","author":"S Roayaie","year":"2009","unstructured":"Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137(3):850\u20135.","journal-title":"Gastroenterology"},{"issue":"8","key":"2399_CR53","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/MCG.0b013e3182a8a254","volume":"48","author":"YH Lee","year":"2014","unstructured":"Lee YH, Hsu CY, Huang YH, Hsia CY, Chiou YY, Su CW, et al. Vascular invasion in hepatocellular carcinoma: prevalence, determinants and prognostic impact. J Clin Gastroenterol. 2014;48(8):734\u201341.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"2399_CR54","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/1097-0142(20000801)89:3<500::AID-CNCR4>3.0.CO;2-O","volume":"89","author":"RT Poon","year":"2000","unstructured":"Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89(3):500\u20137.","journal-title":"Cancer"},{"issue":"2","key":"2399_CR55","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s11605-018-3927-2","volume":"23","author":"SM Jung","year":"2019","unstructured":"Jung SM, Kim JM, Choi GS, Kwon CHD, Yi NJ, Lee KW, et al. Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma. J Gastrointest Surg. 2019;23(2):304\u201311.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"2399_CR56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jamcollsurg.2005.10.005","volume":"202","author":"SA Shah","year":"2006","unstructured":"Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg. 2006;202(2):275\u201383.","journal-title":"J Am Coll Surg"},{"issue":"9","key":"2399_CR57","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1002\/cam4.1738","volume":"7","author":"K Mao","year":"2018","unstructured":"Mao K, Yan Y, Zhang J, Wang J, Wang R, Ling X, et al. The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study. Cancer Med. 2018;7(9):4475\u201384.","journal-title":"Cancer Med"},{"issue":"11","key":"2399_CR58","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1007\/s10620-020-06053-4","volume":"65","author":"SY Ho","year":"2020","unstructured":"Ho SY, Yuan MH, Chen CC, Liu PH, Hsu CY, Huang YH, et al. Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants. Dig Dis Sci. 2020;65(11):3389\u2013402.","journal-title":"Dig Dis Sci"},{"issue":"6","key":"2399_CR59","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1634\/theoncologist.2012-0065","volume":"17","author":"WY Shau","year":"2012","unstructured":"Shau WY, Shao YY, Yeh YC, Lin ZZ, Kuo R, Hsu CH, et al. Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma. Oncologist. 2012;17(6):856\u201362.","journal-title":"Oncologist"},{"issue":"2","key":"2399_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/dmrr.1291","volume":"28","author":"P Wang","year":"2012","unstructured":"Wang P, Kang D, Cao W, Wang Y, Liu Z. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2012;28(2):109\u201322.","journal-title":"Diabetes Metab Res Rev"},{"issue":"12","key":"2399_CR61","doi-asserted-by":"publisher","first-page":"e113858","DOI":"10.1371\/journal.pone.0113858","volume":"9","author":"YY Wang","year":"2014","unstructured":"Wang YY, Huang S, Zhong JH, Ke Y, Guo Z, Liu JQ, et al. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy. PLoS ONE. 2014;9(12):e113858.","journal-title":"PLoS ONE"},{"issue":"6","key":"2399_CR62","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/hep.510270615","volume":"27","author":"Y Ikeda","year":"1998","unstructured":"Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, et al. Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology. 1998;27(6):1567\u201371.","journal-title":"Hepatology"},{"issue":"2","key":"2399_CR63","doi-asserted-by":"publisher","first-page":"e0171129","DOI":"10.1371\/journal.pone.0171129","volume":"12","author":"Q Li","year":"2017","unstructured":"Li Q, Wang Y, Ma T, Lv Y, Wu R. Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis. PLoS ONE. 2017;12(2):e0171129.","journal-title":"PLoS ONE"},{"issue":"5","key":"2399_CR64","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3892\/ijo.2013.2061","volume":"43","author":"H Nishikawa","year":"2013","unstructured":"Nishikawa H, Osaki Y. Non-B, non-C hepatocellular carcinoma (Review). Int J Oncol. 2013;43(5):1333\u201342.","journal-title":"Int J Oncol"},{"issue":"8 Suppl","key":"2399_CR65","first-page":"47S","volume":"27","author":"S Uetake","year":"2003","unstructured":"Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res. 2003;27(8 Suppl):47S-51S.","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"2399_CR66","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1007\/s00535-013-0899-6","volume":"49","author":"A Kudo","year":"2014","unstructured":"Kudo A, Tanaka S, Ban D, Matsumura S, Irie T, Ochiai T, et al. Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis. J Gastroenterol. 2014;49(9):1352\u201361.","journal-title":"J Gastroenterol"},{"issue":"2","key":"2399_CR67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/lt.20934","volume":"13","author":"R Pfitzmann","year":"2007","unstructured":"Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, N\u00fcssler NC. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl. 2007;13(2):197\u2013205.","journal-title":"Liver Transpl"},{"issue":"13","key":"2399_CR68","doi-asserted-by":"publisher","first-page":"8221","DOI":"10.1245\/s10434-021-10317-2","volume":"28","author":"J Kong","year":"2021","unstructured":"Kong J, Li G, Chai J, Yu G, Liu Y, Liu J. Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2021;28(13):8221\u201333.","journal-title":"Ann Surg Oncol"},{"issue":"18","key":"2399_CR69","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.3748\/wjg.v21.i18.5598","volume":"21","author":"DY Ruan","year":"2015","unstructured":"Ruan DY, Lin ZX, Li Y, Jiang N, Li X, Wu DH, et al. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy. World J Gastroenterol. 2015;21(18):5598\u2013606.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2399_CR70","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/SLA.0b013e3181bfda3c","volume":"251","author":"SG Farid","year":"2010","unstructured":"Farid SG, Aldouri A, Morris-Stiff G, Khan AZ, Toogood GJ, Lodge JPA, et al. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 2010;251(1):91\u2013100.","journal-title":"Ann Surg"},{"issue":"3","key":"2399_CR71","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/cancers12030641","volume":"12","author":"MG Refolo","year":"2020","unstructured":"Refolo MG, Messa C, Guerra V, Carr BI, D\u2019Alessandro R. Inflammatory Mechanisms of HCC Development. Cancers (Basel). 2020;12(3):641.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2399_CR72","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/ijc.24409","volume":"125","author":"B McDonald","year":"2009","unstructured":"McDonald B, Spicer J, Giannais B, Fallavollita L, Brodt P, Ferri LE. Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer. 2009;125(6):1298\u2013305.","journal-title":"Int J Cancer"},{"issue":"1","key":"2399_CR73","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1245\/s10434-021-10565-2","volume":"29","author":"T Wei","year":"2022","unstructured":"Wei T, Zhang XF, Bagante F, Ratti F, Marques HP, Silva S, et al. Postoperative Infectious Complications Worsen Long-Term Survival After Curative-Intent Resection for Hepatocellular Carcinoma. Ann Surg Oncol. 2022;29(1):315\u201324.","journal-title":"Ann Surg Oncol"},{"issue":"13","key":"2399_CR74","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1245\/s10434-011-1829-6","volume":"18","author":"NN Rahbari","year":"2011","unstructured":"Rahbari NN, Reissfelder C, Koch M, Elbers H, Striebel F, B\u00fcchler MW, et al. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients. Ann Surg Oncol. 2011;18(13):3640\u20139.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"2399_CR75","doi-asserted-by":"publisher","first-page":"zrac097","DOI":"10.1093\/bjsopen\/zrac097","volume":"6","author":"R Baumgartner","year":"2022","unstructured":"Baumgartner R, Gilg S, Bj\u00f6rnsson B, Hasselgren K, Ghorbani P, Sauter C, et al. Impact of post-hepatectomy liver failure on morbidity and short- and long-term survival after major hepatectomy. BJS Open. 2022;6(4):zrac097.","journal-title":"BJS Open."},{"issue":"4","key":"2399_CR76","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11605-013-2423-y","volume":"18","author":"K Fukushima","year":"2014","unstructured":"Fukushima K, Fukumoto T, Kuramitsu K, Kido M, Takebe A, Tanaka M, et al. Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma. J Gastrointest Surg. 2014;18(4):729\u201336.","journal-title":"J Gastrointest Surg"},{"issue":"2","key":"2399_CR77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00535-022-01946-9","volume":"58","author":"H Nakayama","year":"2023","unstructured":"Nakayama H, Okamura Y, Higaki T, Moriguchi M, Takayama T. Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis. J Gastroenterol. 2023;58(2):171\u201381.","journal-title":"J Gastroenterol"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-024-02399-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-024-02399-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-024-02399-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T12:04:51Z","timestamp":1712577891000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-024-02399-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2399"],"URL":"https:\/\/doi.org\/10.1186\/s12893-024-02399-y","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"22 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local institutional review board (Heinrich Heine University, Duesseldorf, Germany; study-no.: 2021\u20131800- KFogU). All procedures performed in this study were in accordance with the ethical standards in the 1964 Declaration of Helsinki and its later amendments. Informed consent was waived (ethics committee of the Heinrich-Heine-University Duesseldorf, Germany, study-no.: 2021\u20131800- KFogU) because no data regarding the cases were disclosed. The waiver did not affect the rights and welfare of the subjects, and the research topic was not associated with any risk to the subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}